Analgesic Requirements for Post-operative Pain Control in Total Shoulder Replacement Patients: Comparison of Interscalene Single Shot Exparel (Bupivacaine Liposome) Injections to Cervical Paravertebral Catheter With Ropivacaine (0.2% Continuous Infusion)
Status: Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 18 Jul 2019
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine (Primary)
- Indications Intraoperative pain; Postoperative pain
- Focus Therapeutic Use
- Acronyms ETSP
- 15 Jul 2019 Planned End Date changed from 15 Sep 2019 to 15 Nov 2020.
- 15 Jul 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Mar 2020.
- 15 Jul 2019 Planned initiation date changed from 1 May 2019 to 1 Nov 2019.